Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients.

@article{L2005DermalLE,
  title={Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients.},
  author={Monique G. L{\^e} and Rodrigo A Arriagada and Gen{\`e}vieve Contesso and Mohamed Cammoun and Fr{\'e}d{\'e}rique Pfeiffer and Françoise Tabbane and Jacqueline Bahi and Mich{\`e}le Dilaj and Marc Spielmann and Jean-Paul Travagli and Thomas Tursz and Nejib Mourali},
  journal={Clinical breast cancer},
  year={2005},
  volume={6 5},
  pages={
          439-45
        }
}

• Monique G. Lê, Rodrigo A Arriagada, +9 authors Nejib Mourali
• Published 2005 in Clinical breast cancer

BACKGROUND We studied whether dermal lymphatic emboli (DLE) add independent prognostic information to the clinical definition of inflammatory breast cancer (IBC). PATIENTS AND METHODS The study was performed in 2 centers, one each in France and Tunisia. For every patient with IBC, 1-3 patients with noninflammatory breast cancer (non-IBC) were included. All patients were to have a surgical tumor biopsy, including a sample of the skin surrounding the tumor. The endpoint was the risk of a… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed